메뉴 건너뛰기




Volumn 14, Issue 8, 2014, Pages

Desensitizations for chemotherapy and monoclonal antibodies: Indications and outcomes

Author keywords

Acute infusion reaction; Allergy; Anaphylaxis; Basophil activation test; Carboplatin; Chemotherapy; Cisplatin; Desensitization; Hypersensitivity; Infliximab; Monoclonal antibodies; Oxaliplatin; Paclitaxel; Rituximab; Skin testing; Taxanes; Trastuzumab

Indexed keywords

ABATACEPT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETANERCEPT; IMMUNOGLOBULIN E; INFLIXIMAB; MONOCLONAL ANTIBODY; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TRASTUZUMAB;

EID: 84906100993     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0453-5     Document Type: Review
Times cited : (33)

References (38)
  • 1
    • 50649085243 scopus 로고    scopus 로고
    • Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
    • Castells MC, Tennant NM, Sloane DE. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122:574-80.
    • (2008) J Allergy Clin Immunol , vol.122 , pp. 574-580
    • Castells, M.C.1    Tennant, N.M.2    Sloane, D.E.3
  • 3
    • 0033986063 scopus 로고    scopus 로고
    • Paclitaxel-associated hypersensitivity reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center
    • Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J. Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol. 2000;18:102-5. (Pubitemid 30036342)
    • (2000) Journal of Clinical Oncology , vol.18 , Issue.1 , pp. 102-105
    • Markman, M.1    Kennedy, A.2    Webster, K.3    Kulp, B.4    Peterson, G.5    Belinson, J.6
  • 4
    • 65549168690 scopus 로고    scopus 로고
    • Infusion reactions to monoclonal antibodies for solid tumors: Immunologic mechanisms and risk factors
    • Chung CH, O'Neil BH. Infusion reactions to monoclonal antibodies for solid tumors: immunologic mechanisms and risk factors. Oncology. 2009;23:14-7.
    • (2009) Oncology , vol.23 , pp. 14-17
    • Chung, C.H.1    O'Neil, B.H.2
  • 5
    • 84883165337 scopus 로고    scopus 로고
    • Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
    • This article identified BRCA1/2 mutation carriers to be higher risk for platinum agent hypersensitivity
    • Moon DH, Lee JM, Noonan AM, Annunziata CM, Minasian L, Houston N, et al. Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. Br J of Cancer. 2013;109:1072-8. This article identified BRCA1/2 mutation carriers to be higher risk for platinum agent hypersensitivity.
    • (2013) Br J of Cancer , vol.109 , pp. 1072-1078
    • Moon, D.H.1    Lee, J.M.2    Noonan, A.M.3    Annunziata, C.M.4    Minasian, L.5    Houston, N.6
  • 6
    • 78649241782 scopus 로고    scopus 로고
    • General considerations on rapid desensitization for drug hypersensitivity: A consensus statement
    • Cernadas JR, Brockow K, Romano A, et al. General considerations on rapid desensitization for drug hypersensitivity: a consensus statement. Allergy. 2010;65:1357-66.
    • (2010) Allergy , vol.65 , pp. 1357-1366
    • Cernadas, J.R.1    Brockow, K.2    Romano, A.3
  • 7
    • 84891656768 scopus 로고    scopus 로고
    • Successful outpatient graded administration of trimethoprim- sulfamethoxazole in patients without HIV and a history of sulfonamide adverse drug reaction
    • Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, et al. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and a history of sulfonamide adverse drug reaction. J Allergy Clin Immunol Pract. 2014;2:52-8.
    • (2014) J Allergy Clin Immunol Pract , vol.2 , pp. 52-58
    • Pyle, R.C.1    Butterfield, J.H.2    Volcheck, G.W.3    Podjasek, J.C.4    Rank, M.A.5    Li, J.T.6
  • 8
    • 84866017960 scopus 로고    scopus 로고
    • Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer
    • This article suggests that basophil activation test may help predict carboplatin-related anaphylaxis
    • Iwamoto T, Yuta A, Tabata T, et al. Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer. Biol Pharm Bull. 2012;35(9):1487-95. This article suggests that basophil activation test may help predict carboplatin-related anaphylaxis.
    • (2012) Biol Pharm Bull , vol.35 , Issue.9 , pp. 1487-1495
    • Iwamoto, T.1    Yuta, A.2    Tabata, T.3
  • 9
    • 84891657716 scopus 로고    scopus 로고
    • Oxaliplatin hypersensitivity: Evaluation, implications of skin testing, and desensitization
    • The first large retrospective series of oxaliplatin hypersensitivity in 48 patients treated with 200 successful desensitizations
    • Wong JT, Ling M, Patil B, Banerji A, Long A. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. J Allergy Clin Immunol Pract. 2014;2:40-5. The first large retrospective series of oxaliplatin hypersensitivity in 48 patients treated with 200 successful desensitizations.
    • (2014) J Allergy Clin Immunol Pract , vol.2 , pp. 40-45
    • Wong, J.T.1    Ling, M.2    Patil, B.3    Banerji, A.4    Long, A.5
  • 10
    • 18144392975 scopus 로고    scopus 로고
    • 2) in the treatment of gynecologic cancers
    • DOI 10.1016/j.ygyno.2004.12.057
    • Kim RJ, Peterson G, Kulp B, et al. Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers. Gynecol Oncol. 2005;97:374-8. (Pubitemid 40614877)
    • (2005) Gynecologic Oncology , vol.97 , Issue.2 , pp. 374-378
    • Kim, R.J.1    Peterson, G.2    Kulp, B.3    Zanotti, K.M.4    Markman, M.5
  • 12
    • 1542438610 scopus 로고    scopus 로고
    • Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity
    • DOI 10.1200/JCO.2003.05.539
    • Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol. 2003;21:4611-4. (Pubitemid 46594035)
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.24 , pp. 4611-4614
    • Markman, M.1    Zanotti, K.2    Peterson, G.3    Kulp, B.4    Webster, K.5    Belinson, J.6
  • 13
    • 73449120788 scopus 로고    scopus 로고
    • Carboplatin hypersensitivity: Does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study
    • Gomez R, Harter P, Luck HJ, Traut A, Kommoss S, Kandel M, et al. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study. Int J Gynecol Cancer. 2009;19:1284-7.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 1284-1287
    • Gomez, R.1    Harter, P.2    Luck, H.J.3    Traut, A.4    Kommoss, S.5    Kandel, M.6
  • 14
    • 84856443686 scopus 로고    scopus 로고
    • A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions
    • Patil S, Long A, Ling M, et al. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. J Allergy Clin Immunol. 2012;129:443-7.
    • (2012) J Allergy Clin Immunol , vol.129 , pp. 443-447
    • Patil, S.1    Long, A.2    Ling, M.3
  • 15
    • 71349084892 scopus 로고    scopus 로고
    • Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
    • Brennan PJ, Rodriguez Bouza T, Hsu F, et al. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124:1259-66.
    • (2009) J Allergy Clin Immunol , vol.124 , pp. 1259-1266
    • Brennan, P.J.1    Rodriguez Bouza, T.2    Hsu, F.3
  • 16
    • 84878358699 scopus 로고    scopus 로고
    • Allerogological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
    • Matucci A, Pratesi S, Petroni G, et al. Allerogological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. Clin Exp Allergy. 2013;43:659-64.
    • (2013) Clin Exp Allergy , vol.43 , pp. 659-664
    • Matucci, A.1    Pratesi, S.2    Petroni, G.3
  • 17
    • 4344610304 scopus 로고    scopus 로고
    • Clinical features and severity grading of anaphylaxis
    • DOI 10.1016/j.jaci.2004.04.029, PII S0091674904013983
    • Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114:371-6. (Pubitemid 39119039)
    • (2004) Journal of Allergy and Clinical Immunology , vol.114 , Issue.2 , pp. 371-376
    • Brown, S.G.A.1
  • 18
    • 0036200063 scopus 로고    scopus 로고
    • Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy
    • DOI 10.1006/gyno.2001.6519
    • Dizon DS, Sabbatini PJ, Aghajanian C, et al. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development after a carboplatin allergy. Gynecol Oncol. 2002;84(3):378-82. (Pubitemid 34211861)
    • (2002) Gynecologic Oncology , vol.84 , Issue.3 , pp. 378-382
    • Dizon, D.S.1    Sabbatini, P.J.2    Aghajanian, C.3    Hensley, M.L.4    Spriggs, D.R.5
  • 19
    • 76649118099 scopus 로고    scopus 로고
    • Administration of cisplatin in three patients with carboplatin hypersensitivity: Is skin testing useful?
    • Syrigou E, Nektaria M, Vassias A, et al. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful? Anti-Cancer Drugs. 2010;21:333-8.
    • (2010) Anti-Cancer Drugs , vol.21 , pp. 333-338
    • Syrigou, E.1    Nektaria, M.2    Vassias, A.3
  • 20
    • 67649171726 scopus 로고    scopus 로고
    • Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management
    • Hesterberg P, Banerji A, Oren E, et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol. 2009;129:1262-7.
    • (2009) J Allergy Clin Immunol , vol.129 , pp. 1262-1267
    • Hesterberg, P.1    Banerji, A.2    Oren, E.3
  • 21
    • 84883326695 scopus 로고    scopus 로고
    • Carboplatin, oxaliplatin and cisplatin-specific IgE: Cross reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy
    • Once validated, specific IgE may be useful in risk-stratifying patients
    • Caiado J, Pereira-Santos MC VL, Costa L, Barbosa M, Castells M. Carboplatin, oxaliplatin and cisplatin-specific IgE: cross reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy. J Allergy Clin Immunol: In Practice. 2013;1:494-500. Once validated, specific IgE may be useful in risk-stratifying patients.
    • (2013) J Allergy Clin Immunol: In Practice , vol.1 , pp. 494-500
    • Caiado, J.1    Pereira-Santos, M.C.2    V, L.3    Costa, L.4    Barbosa, M.5    Castells, M.6
  • 22
    • 84880302626 scopus 로고    scopus 로고
    • Hypersensitivity and desensitization to antineoplastic agents: Outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment
    • A new shorter desensitization protocol
    • Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, Ferreiro-Monteagudo R, Ruillen-Ponce C, Pueyo C, et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy. 2013;68(7):853-61. A new shorter desensitization protocol.
    • (2013) Allergy , vol.68 , Issue.7 , pp. 853-861
    • Madrigal-Burgaleta, R.1    Berges-Gimeno, M.P.2    Angel-Pereira, D.3    Ferreiro-Monteagudo, R.4    Ruillen-Ponce, C.5    Pueyo, C.6
  • 23
    • 84867909612 scopus 로고    scopus 로고
    • Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test
    • This article also evaluates basophil activation test as a possible marker for predication of anaphylaxis
    • Piva E, Chieco-Bianchi F, Krajcar V, et al. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: in vitro evaluation of rituximab hypersensitivity by basophil activation test. Am J Hematol. 2012;87(11):E130-1. This article also evaluates basophil activation test as a possible marker for predication of anaphylaxis.
    • (2012) Am J Hematol , vol.87 , Issue.11
    • Piva, E.1    Chieco-Bianchi, F.2    Krajcar, V.3
  • 24
    • 79955134975 scopus 로고    scopus 로고
    • A new rapid desensitization protocol for chemotherapy agents
    • This article reviews a desensitization protocol that is shorter and a premedication regimen based on radiocontrast allergy
    • Gastaminza G, de la Borbolla JM, Goikoetxea MJ, Escudero R, Anton J, Espinos J, et al. A new rapid desensitization protocol for chemotherapy agents. J Investig Allergol Clin Immunol. 2011;21(2):108-12. This article reviews a desensitization protocol that is shorter and a premedication regimen based on radiocontrast allergy.
    • (2011) J Investig Allergol Clin Immunol , vol.21 , Issue.2 , pp. 108-112
    • Gastaminza, G.1    De La Borbolla, J.M.2    Goikoetxea, M.J.3    Escudero, R.4    Anton, J.5    Espinos, J.6
  • 25
    • 40849142102 scopus 로고    scopus 로고
    • Cetuximab-induced anaphylaxis and IgE specific fort galactose-α-1, 3-galactose
    • Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific fort galactose-α-1,3-galactose. N Engl J Med. 2008;358:1009-17.
    • (2008) N Engl J Med , vol.358 , pp. 1009-1017
    • Chung, C.H.1    Mirakhur, B.2    Chan, E.3
  • 26
    • 79955613976 scopus 로고    scopus 로고
    • The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1, 3-galactose
    • Commins SP, James HR, Kelly LA, Pochan SL, Workman LJ, Perzanowski MS, et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1, 3-galactose. J Allergy Clin Immunol. 2011;127(5):1286-93.
    • (2011) J Allergy Clin Immunol , vol.127 , Issue.5 , pp. 1286-1293
    • Commins, S.P.1    James, H.R.2    Kelly, L.A.3    Pochan, S.L.4    Workman, L.J.5    Perzanowski, M.S.6
  • 27
    • 77957893019 scopus 로고    scopus 로고
    • Drug Allergy. An updated practice parameter
    • Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology
    • Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Drug Allergy. An updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259-73.
    • (2010) Ann Allergy Asthma Immunol , vol.105 , Issue.4 , pp. 259-273
  • 28
    • 79958779443 scopus 로고    scopus 로고
    • Platinum agent-induced hypersensitivity reactions: Data mining of the public version of the FDA Adverse Event Reporting System
    • Sakaeda T, Kadoyama K, Yabuuchi H, Niijima S, Seki K, Shiraishi Y, et al. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA Adverse Event Reporting System. AERS Int J Med Sci. 2011;8(4):332-8.
    • (2011) AERS Int J Med Sci , vol.8 , Issue.4 , pp. 332-338
    • Sakaeda, T.1    Kadoyama, K.2    Yabuuchi, H.3    Niijima, S.4    Seki, K.5    Shiraishi, Y.6
  • 30
    • 60849092276 scopus 로고    scopus 로고
    • Acetylsalicyclic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization
    • Breslow RG, Caiado J, Castells MC. Acetylsalicyclic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102:155-60.
    • (2009) Ann Allergy Asthma Immunol , vol.102 , pp. 155-160
    • Breslow, R.G.1    Caiado, J.2    Castells, M.C.3
  • 31
    • 79955573063 scopus 로고    scopus 로고
    • Immediate adverse reactions to biologicals: From pathogenic mechanisms to prophylactic management
    • Vultaggio A, Maggi E, Matucci A. Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management. Curr Opin Allergy Clin Immunol. 2013;11:262-8.
    • (2013) Curr Opin Allergy Clin Immunol , vol.11 , pp. 262-268
    • Vultaggio, A.1    Maggi, E.2    Matucci, A.3
  • 32
    • 84891648510 scopus 로고    scopus 로고
    • Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels
    • This case report presents the added benefit of using omalizumab for drug desensitization
    • Ojaimi S, Harnett PR, Fulcher DA. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels. J Allergy Clin Immunol Pract. 2014;2:105-6. This case report presents the added benefit of using omalizumab for drug desensitization.
    • (2014) J Allergy Clin Immunol Pract , vol.2 , pp. 105-106
    • Ojaimi, S.1    Harnett, P.R.2    Fulcher, D.A.3
  • 33
    • 79953038437 scopus 로고    scopus 로고
    • Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcepsilonRI internalization
    • Sancho-Serra Mdel C, Simarro M, Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcepsilonRI internalization. Eur J Immunol. 2011;41:1004-13.
    • (2011) Eur J Immunol , vol.41 , pp. 1004-1013
    • Sancho-Serra Mdel, C.1    Simarro, M.2    Castells, M.3
  • 34
    • 19044372321 scopus 로고    scopus 로고
    • Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen
    • Morales AR, Shah N, Castells M. Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen. Ann Allergy Asthma Immunol. 2005;94:575-80. (Pubitemid 40712782)
    • (2005) Annals of Allergy, Asthma and Immunology , vol.94 , Issue.5 , pp. 575-580
    • Morales, A.R.1    Shah, N.2    Castells, M.3
  • 35
    • 84881119249 scopus 로고    scopus 로고
    • Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization
    • This case report also highlights increased in Treg cells after a successful desensitization
    • Aydogan M, Yologlu N, Gacar G, et al. Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: increase in number of Treg cells after desensitization. J Allergy Clin Immunol. 2013;132(2):478-80. This case report also highlights increased in Treg cells after a successful desensitization.
    • (2013) J Allergy Clin Immunol , vol.132 , Issue.2 , pp. 478-480
    • Aydogan, M.1    Yologlu, N.2    Gacar, G.3
  • 36
    • 84885765269 scopus 로고    scopus 로고
    • Drug desensitizations in the management of allergy and anaphylaxis to chemotherapeutic agents and monoclonal antibodies
    • Castells MC, editor. New York: Humana Press
    • Banerji A, Brennan P, Hesterberg P, et al. Drug desensitizations in the management of allergy and anaphylaxis to chemotherapeutic agents and monoclonal antibodies. In: Castells MC, editor. Anaphylaxis and Hypersensitivity Reactions. New York: Humana Press; 2011. p. 297-311.
    • (2011) Anaphylaxis and Hypersensitivity Reactions , pp. 297-311
    • Banerji, A.1    Brennan, P.2    Hesterberg, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.